Current Price Status
Stock is Shooting to the Moon
Stock is over-priced on the upper end by the market with the expectation of annual earning growth at 64.94% to match current price.
Stock in booming mode can be traded very volatile, price can swing largely day-to-day. While having big upside potential, the downside risk can be huge if the stock is not meeting the market expectation.
Company is in Positive Earning
- TMCLIFE current price is 19.05% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
OutperformedTMCLIFE past 5-day return perform better than Medical Services industry average return by 6.14%
Below 30-Day AverageCurrent price RM0.75 is below 30-day average RM0.76 by 1.3%
|Return (%)||TMCLIFE||Medical Services|
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
High Volatile Revenue Growth
TMCLIFE experienced high unstable ups & downs on revenue growth for past 4 quarters with average 83% range on both sides.
Unstable Profit Growth
TMCLIFE has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
TMCLIFE recent daily traded volume is -55.56% lower than past month average.
|Past 30-Day||Past 5-Day|
|9k daily||4k daily|
Price History Chart
Past 30-day Average Price: RM0.76
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Stock Company Profile
TMC LIFE SCIENCES BHD
TMC Life Sciences Bhd. operates as an investment holding company, which, through its subsidiaries, engages in the business of multi-disciplinary tertiary care services, provision of fertility services and operation of women's clinic, provision of consultancy, laboratory, and embryology services, development, marketing, and management of healthcare programs, property investment; gynecological and fertility problem management, and marketing and promoting of healthcare products. The company was founded by Soon Soo Lee in January 1994 and is headquartered in Petaling Jaya, Malaysia.